Evidence-Based Medicine Guidelines
Tumour necrosis factor alpha blocking agents (infliximab) for induction of remission in ulcerative colitis
Tumour necrosis factor alpha blocking agents (infliximab) for induction of remission in ulcerative colitis is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tumour Necrosis Factor Alpha Blocking Agents (infliximab) for Induction of Remission in Ulcerative Colitis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450756/all/Tumour_necrosis_factor_alpha_blocking_agents__infliximab__for_induction_of_remission_in_ulcerative_colitis.
Tumour necrosis factor alpha blocking agents (infliximab) for induction of remission in ulcerative colitis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450756/all/Tumour_necrosis_factor_alpha_blocking_agents__infliximab__for_induction_of_remission_in_ulcerative_colitis. Accessed March 24, 2023.
Tumour necrosis factor alpha blocking agents (infliximab) for induction of remission in ulcerative colitis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450756/all/Tumour_necrosis_factor_alpha_blocking_agents__infliximab__for_induction_of_remission_in_ulcerative_colitis
Tumour Necrosis Factor Alpha Blocking Agents (infliximab) for Induction of Remission in Ulcerative Colitis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450756/all/Tumour_necrosis_factor_alpha_blocking_agents__infliximab__for_induction_of_remission_in_ulcerative_colitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tumour necrosis factor alpha blocking agents (infliximab) for induction of remission in ulcerative colitis
ID - 450756
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450756/all/Tumour_necrosis_factor_alpha_blocking_agents__infliximab__for_induction_of_remission_in_ulcerative_colitis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
